Can Fite Biopharma
CANF
$1.94
Share price
-1.52%
Change (1 day)
14.12%
Change (1 year)
Categories
Revenue for Can Fite Biopharma (CANF)
Revenue in 2023 (TTM): $0.74 M
According to Can Fite Biopharma 's latest financial reports the company's current revenue (TTM) is $0.74 M. In 2022 the company made a revenue of $0.81 M a decrease over the years 2021 revenue that were of $0.85 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Can Fite Biopharma from 2011 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.74 M | -8.27% |
| 2022 | $0.81 M | -5.04% |
| 2021 | $0.85 M | 11.8% |
| 2020 | $0.76 M | -62.45% |
| 2019 | $2.03 M | -46.81% |
| 2018 | $3.82 M | 355.12% |
| 2017 | $0.83 M | 395.18% |
| 2016 | $0.16 M | 2.9% |
| 2015 | $0.16 M | |
| 2014 | N/A | |
| 2013 | N/A | |
| 2012 | N/A | -100% |
| 2011 | $0.48 M |